WEST PHARMACEUTICAL SERVICES (WST) Stock Price, Forecast & Analysis
NYSE:WST • US9553061055
WST Key Statistics, Chart & Performance
The current stock price of WST is 244.22 USD. In the past month the price increased by 3.19%. In the past year, price increased by 5.11%.
WST Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to WST. When comparing the yearly performance of all stocks, WST is a bad performer in the overall market: 71.37% of all stocks are doing better.
WST Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to WST. WST scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
WST Financial Highlights
Over the last trailing twelve months WST reported a non-GAAP Earnings per Share(EPS) of 7.29. The EPS increased by 8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.06% | ||
| ROA | 11.56% | ||
| ROE | 15.54% | ||
| Debt/Equity | 0.06 |
WST Forecast & Estimates
23 analysts have analysed WST and the average price target is 353.41 USD. This implies a price increase of 44.71% is expected in the next year compared to the current price of 244.22.
For the next year, analysts expect an EPS growth of 7.67% and a revenue growth 6.11% for WST
WST Ownership
WST Latest News, Press Relases and Analysis
WST Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.81 | 191.962B | ||
| DHR | DANAHER CORP | 24.83 | 148.096B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 141.98 | 46.374B | ||
| A | AGILENT TECHNOLOGIES INC | 20.52 | 34.761B | ||
| IQV | IQVIA HOLDINGS INC | 12.41 | 28.089B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 30.14 | 28.006B | ||
| WAT | WATERS CORP | 22.66 | 19.843B | ||
| ILMN | ILLUMINA INC | 23.28 | 17.98B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.47 | 12.783B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About WST
Company Profile
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Company Info
WEST PHARMACEUTICAL SERVICES
530 Herman O. West Drive
Exton PENNSYLVANIA 19341 US
CEO: Eric M. Green
Employees: 10600
Phone: 18006222300
WEST PHARMACEUTICAL SERVICES / WST FAQ
What does WST do?
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
What is the current price of WST stock?
The current stock price of WST is 244.22 USD. The price increased by 1.29% in the last trading session.
What is the dividend status of WEST PHARMACEUTICAL SERVICES?
WEST PHARMACEUTICAL SERVICES (WST) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.85.
How is the ChartMill rating for WEST PHARMACEUTICAL SERVICES?
WST has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the ex-dividend date for WST stock?
The next ex-dividend date for WEST PHARMACEUTICAL SERVICES (WST) is January 28, 2026.
What is the employee count for WST stock?
WEST PHARMACEUTICAL SERVICES (WST) currently has 10600 employees.
What is the ownership structure of WEST PHARMACEUTICAL SERVICES (WST)?
You can find the ownership structure of WEST PHARMACEUTICAL SERVICES (WST) on the Ownership tab.